CoChat

Advances in high‐throughput mass spectrometry in drug discovery

Open access
Dueñas, Maria Emilia, Peltier‐Heap, Rachel E, Leveridge, Melanie, Annan, Roland S, Büttner, Frank H, Trost, Matthias · 2023 · EMBO Molecular Medicine
Cited by 122

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

High-throughput (HT) screening drug discovery, during which thousands or millions of compounds are screened, remains the key methodology for identifying active chemical matter in early drug discovery pipelines. Recent technological developments in mass spectrometry (MS) and automation have revolutionized the application of MS for use in HT screens. These methods allow the targeting of unlabelled biomolecules in HT assays, thereby expanding the breadth of targets for which HT assays can be developed compared to traditional approaches. Moreover, these label-free MS assays are often cheaper, faster, and more physiologically relevant than competing assay technologies. In this review, we will describe current MS techniques used in drug discovery and explain their advantages and disadvantages. We will highlight the power of mass spectrometry in label-free in vitro assays, and its application for setting up multiplexed cellular phenotypic assays, providing an exciting new tool for screening compounds in cell lines, and even primary cells. Finally, we will give an outlook on how technological advances will increase the future use and the capabilities of mass spectrometry in drug discovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/emmm.202114850

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 122

Metadata

Authors
Dueñas, M. E., Peltier‐Heap, R. E., Leveridge, M., Annan, R. S., Büttner, F. H., & Trost, M.
Venue
EMBO Molecular Medicine
Published
2022-12-14
Volume
15
Issue
1
Pages
e14850-e14850
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W4311480785
Cited by
122
References
13
FWCI
8.38
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advances in high‐throughput mass spectrometry in drug discovery. https://app.cochat.ai/papers/10.15252/emmm.202114850
The paper
Dueñas, M. E., Peltier‐Heap, R. E., Leveridge, M., Annan, R. S., Büttner, F. H., & Trost, M. (2023). Advances in high‐throughput mass spectrometry in drug discovery. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.202114850

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.